ZA878881B - Medicaments based on derivatives of 3,4-diphenylpiperidine,the use of the derivatives as medicaments,and novel 3,4-diphenylpiperidine derivatives and a process for the preparation thereof - Google Patents

Medicaments based on derivatives of 3,4-diphenylpiperidine,the use of the derivatives as medicaments,and novel 3,4-diphenylpiperidine derivatives and a process for the preparation thereof

Info

Publication number
ZA878881B
ZA878881B ZA878881A ZA878881A ZA878881B ZA 878881 B ZA878881 B ZA 878881B ZA 878881 A ZA878881 A ZA 878881A ZA 878881 A ZA878881 A ZA 878881A ZA 878881 B ZA878881 B ZA 878881B
Authority
ZA
South Africa
Prior art keywords
derivatives
diphenylpiperidine
medicaments
novel
preparation
Prior art date
Application number
ZA878881A
Other languages
English (en)
Inventor
Serge Petit
Petit Serge
Jean-Pierre Nallet
Nallet Jean-Pierre
Jacques Dreux
Dreux Jacques
Jacqueline Winieki
Winieki Jacqueline
Original Assignee
Hoechst Sa Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Sa Lab filed Critical Hoechst Sa Lab
Publication of ZA878881B publication Critical patent/ZA878881B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA878881A 1986-11-27 1987-11-26 Medicaments based on derivatives of 3,4-diphenylpiperidine,the use of the derivatives as medicaments,and novel 3,4-diphenylpiperidine derivatives and a process for the preparation thereof ZA878881B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863640475 DE3640475A1 (de) 1986-11-27 1986-11-27 Arzneimittel auf basis von derivaten des 3,4-diphenylpiperidins, die verwendung der derivate als arzneimittel sowie neue 3,4-diphenylpiperidinderivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
ZA878881B true ZA878881B (en) 1988-10-26

Family

ID=6314857

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA878881A ZA878881B (en) 1986-11-27 1987-11-26 Medicaments based on derivatives of 3,4-diphenylpiperidine,the use of the derivatives as medicaments,and novel 3,4-diphenylpiperidine derivatives and a process for the preparation thereof

Country Status (9)

Country Link
EP (1) EP0273199A3 (fr)
JP (1) JPS63141965A (fr)
KR (1) KR880006194A (fr)
AU (1) AU8182187A (fr)
DE (1) DE3640475A1 (fr)
DK (1) DK621187A (fr)
IE (1) IE873212L (fr)
PT (1) PT86211B (fr)
ZA (1) ZA878881B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6376672B1 (en) * 1999-04-27 2002-04-23 Hoffmann-La Roche Inc. Naphthalenylmethoxypiperidines as renin inhibitors
JP2005514362A (ja) * 2001-11-19 2005-05-19 イーラン ファーマスーティカルズ、インコーポレイテッド ３，４二置換、３，５二置換、及び３，４，５置換ピペリジン及びピペラジン
CA2521258C (fr) 2003-04-04 2009-12-01 H. Lundbeck A/S Derives 4-(2-phenylsulfanyl-phenyl)-piperidines utilises en tant qu'inhibiteurs de reabsorption de la serotonine
ATE396970T1 (de) 2003-12-23 2008-06-15 Lundbeck & Co As H 2-(1h-indolylsulfanyl)-benzylaminderivate als ssri
AR052308A1 (es) 2004-07-16 2007-03-14 Lundbeck & Co As H Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto
US7629473B2 (en) 2005-06-17 2009-12-08 H. Lundbeck A/S 2-(1H-indolylsulfanyl)-aryl amine derivatives
AR054393A1 (es) 2005-06-17 2007-06-20 Lundbeck & Co As H Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos.

Also Published As

Publication number Publication date
DK621187D0 (da) 1987-11-26
EP0273199A3 (fr) 1988-07-20
AU8182187A (en) 1988-06-02
JPS63141965A (ja) 1988-06-14
KR880006194A (ko) 1988-07-22
PT86211B (pt) 1990-11-07
IE873212L (en) 1988-05-27
DE3640475A1 (de) 1988-06-09
DK621187A (da) 1988-05-28
PT86211A (de) 1987-12-01
EP0273199A2 (fr) 1988-07-06

Similar Documents

Publication Publication Date Title
HU900238D0 (en) Process for preparation of 1,4-disubstituted-piperidine-ketone derivatives
KR950010075B1 (en) Process for the preparation of 1,2,3,6-tetrahydro-5-nitro-pyrimidine derivatives
HUT47103A (en) Process for producing 1,4-benzoxazine derivatives and pharmaceutical compositions comprising the same
DE3662104D1 (en) 4'-demethyl-4-epipodophyllotoxin derivatives, a process for their preparation and their use as medicaments
ZA875043B (en) 7-acyloxy-6-aminoacyloxypolyoxylabdanes,a process for their preparation,and their use as medicaments
ZA901765B (en) Derivatives of thieno-triazolo-diazepine,a preparation process of the same and therapeutic compositions containing them
IL86027A (en) 2-acylpyrrolidine derivatives,a process for the preparation thereof,compositions containing them,and their use
EP0264744A3 (en) Process for the preparation of 4,4'-diaminodiphenylmethane and its derivatives.
ZA903305B (en) Thieno-triazolo-diazepine derivatives,a preparation process of the same and therapeutic compositions containing them
PT83801B (en) Process for preparing 6,7,8,9/tetrahydro-10-methylpyrido]1,2-a"indol-9-amines and derivatives thereof
EP0236929A3 (en) 1,2-dithiol-3-thione derivatives, a process for preparing them and a pharmaceutical composition containing them
AU8182187A (en) Medicaments based on derivatives of 3,4-diphenylpiperidine the use of the derivatives as medicaments, and novel 3,4- diphenylpiperidine derivatives and a process for the preparation thereof
ZA879694B (en) Novel carbamoyloxylabdanes,intermediates and a process for the preparation thereof and their use as medicaments
IL82294A0 (en) 1,3-dihydropyridine derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
EP0334097A3 (en) Process for the preparation of 4,4'-dihalogeno-bisphenyls
GR871209B (en) 2,3,4,5,67, - exhydro -2,7 methano -1,5 - benzoxazonin derivatives preparation method and medicaments containing said compound
ZA878659B (en) 12-halogenated forskolin derivatives,intermediates and a process for the preparation thereof and their use as medicaments
PT83884A (en) Process for the preparation of 1 azolyl-3,3-dimethyl-tutan-2-on-and-ol derivatives
PT85392A (en) Process for the preparation of 2,4-diamino-3-oxy-6-piperidylpurimidine
DE3760307D1 (en) Process for the preparation of 1,1,2-trialkoxyethane
PT81880A (en) (1,2,4-oxadiazol-3-yl)-arymethanones a process for their preparation and their use as medicaments
EP0347021A3 (en) Process for the preparation of 2,3-dimethoxy-5-methylbenzoquinone
ZA888194B (en) New acyllabdane derivatives,a process for their preparation,and their use as medicaments
ZA875689B (en) Process for the preparation of 2,4-diamino-5-benzylpyrimidines
NZ220805A (en) Cytorhodin s derivatives,a process for their preparation and their use as medicaments